Improving CAR-T cell therapy, step-by-step
| dc.rights.license | CC-BY-NC-ND | |
| dc.contributor.advisor | Schiffelers, Raymond | |
| dc.contributor.author | Tummers, Isa | |
| dc.date.accessioned | 2024-07-18T23:01:40Z | |
| dc.date.available | 2024-07-18T23:01:40Z | |
| dc.date.issued | 2024 | |
| dc.identifier.uri | https://studenttheses.uu.nl/handle/20.500.12932/46770 | |
| dc.description.sponsorship | Utrecht University | |
| dc.language.iso | EN | |
| dc.subject | This review explores the bottlenecks in every step of the CAR-T cell production process, focusing on T cell isolation, genetic modification, T cell expansion, and good manufacturing practice (GMP) regulations. It studies the advantages and disadvantages of various solutions and looks into completely new ways of CAR-T cell production. | |
| dc.title | Improving CAR-T cell therapy, step-by-step | |
| dc.type.content | Master Thesis | |
| dc.rights.accessrights | Open Access | |
| dc.subject.courseuu | Drug Innovation | |
| dc.thesis.id | 34200 |